What Is/Jdrf/Chesapeake/Researching Type 1 Diabetes
We are JDRF – Juvenile Diabetes Research Foundation. We won’t stop until we create a world without T1D (type one diabetes). We are committed to eradicating type 1 diabetes and its effects for everyone with type 1, and at risk of developing it. T1D treatment options are improving all the time. We are driving research to improve the technology people with T1D use to monitor blood sugar levels and research that will ultimately deliver a cure.
Diabetes is a lifelong condition that causes a person’s blood sugar (glucose) level to become too high. The hormone insulin – is responsible for controlling the amount of glucose in the blood.
JDRF’s Mission: is to prevent and cure diabetes and to improve the lives of all people affected by this disease.
JDRF – the type 1 diabetes charity. Join the worldwide army of people who are making it their personal mission to fight type 1 diabetes. Together, we will create a world without type 1 diabetes. Here you can find the full list of Credits http://broadcaster.beazil.net/public/credits/youtube/videos/42315 Chesapeake is an independent city located in the U.S. commonwealth of Virginia. As of the 2010 census, the population was 222,209, in 2013, the population was estimated to be 232,977, making it the third-most populous city in Virginia.
Chesapeake is included in the Virginia Beach–Norfolk–Newport News, VA–NC MSA. One of the cities in the South Hampton Roads, Chesapeake was organized in 1963 by voter referendums approving the political consolidation of the city of South Norfolk with the remnants of the former Norfolk County, which dated to 1691. (Much of the territory of the county had been annexed by other cities.) Chesapeake is the second-largest city by land area in the Commonwealth of Virginia.
In 2011, Chesapeake was named the 21st best city in America by Bloomberg Businessweek. People with T1D would never benefit from JDRF-funded innovations without our donors. The work to create transformational therapies to help people live with T1D cannot—and must not—be allowed to stop because dedicated researchers lack funds. Laboratory studies that are unlocking the mysteries of T1D and accelerating progress toward a cure and prevention must continue. With the generous help of supporters, JDRF is pursuing a diversified, dynamic research agenda that is moving us ever closer to a world without T1D.
JDRF is committed to doing the greatest good, for the largest number of people, in the shortest amount of time so we understand the importance of funding these trials. Today more than 50 human trials, studying life-changing drugs, treatments and devices, are under way with our support. That’s 10 times the number less than a decade ago! Health Care & Social Assistance sector comprises firms providing health care and social assistance for individuals. The sector includes both health care and social assistance because it is sometimes difficult to distinguish between the boundaries of these two activities. The industries in this sector are arranged on a continuum starting with providing medical care exclusively, continuing with those providing health care and social assistance and finally finishing with only social assistance. The services provided in this sector are delivered by trained health practitioners and social workers with requisite experience. JDRF is the leading global organization funding type 1 diabetes (T1D) research. JDRF’s goal is to progressively remove the impact of T1D from people’s lives until we achieve a world without T1D. JDRF has led the search for a cure for T1D since our founding in 1970. In those days, people commonly called the disease “juvenile diabetes” because it was frequently diagnosed in, and strongly associated with, young children. Our organization began as the Juvenile Diabetes Foundation. Later, to emphasize exactly how we planned to end the disease, we added a word and became the Juvenile Diabetes Research Foundation.Today, we know an equal number of children and adults are diagnosed every day—approximately 110 people per day.
Here are the main points of the mentioned above:
A1C complications,Aldesleukin,CRFD mortality,brittle diabetes,Children’s Congress,Living with Type 1,The Promise Campaign,First time with insulin pump,very-low-density lipoprotein cholesterol,new treatment,Glucose Modulating Agents,Blood Glucose Level,research,sugar breakdown,Blood Glucose Meters,Type 1 Diabetes,cholesterol levels,IGT,The Old Dominion State,prevention of complications,Kussmaul breathing,donate to help,permanent insulinopenia,diabetes symptoms,raise money,Robert Wood Johnson IV,sulfonylurea,adult-onset diabetes,70/30 insulin,Estrogen in Type 1 Diabetes,Fast Acting Insulin,low blood glucose,Mary Tyler Moore,VLDL cholesterol,The Automation to Simulate Pancreatic Insulin Response Trial,advocating for government support,Basal Insulin,A1C Test,implantable insulin pump,Recipe Swap,make a contribution,adult-onset.